(NVS) Novartis - Performance 16.8% in 12m

NVS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 63.41%
#10 in Peer-Group
Rel. Strength 63.57%
#2797 in Stock-Universe
Total Return 12m 16.79%
#51 in Peer-Group
Total Return 5y 78.38%
#20 in Peer-Group
P/E Value
P/E Trailing 18.5
P/E Forward 14.0
High / Low USD
52 Week High 123.81 USD
52 Week Low 93.41 USD
Sentiment Value
VRO Trend Strength +-100 81.86
Buy/Sell Signal +-5 -0.31
Support / Resistance Levels
Support
Resistance
12m Total Return: NVS (16.8%) vs XLV (-4.6%)
Total Return of Novartis versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (NVS) Novartis - Performance 16.8% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
NVS 1.57% 4.24% 15.2%
NKTR -3.88% 121% 199%
PHAT -8.42% 89.8% 82.8%
MIST 4.30% 17.6% 179%

Long Term Performance

Symbol 6m 12m 5y
NVS 29.3% 16.8% 78.4%
VRNA 104% 468% 1,760%
ALTS 40.2% 292% 155%
AMLX 60.7% 266% -65.1%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
3.27% 140% 332% 64.3 57.8 0.61 23.7% -5.15%
NVS NYSE
Novartis
4.24% 16.8% 78.4% 18.5 14 1.37 8.70% 9.2%
LLY NYSE
Eli Lilly
1.94% -14.1% 396% 63.3 35.6 1.19 58.2% 18.9%
NOVN SW
Novartis
0.79% 3.78% 49.4% 18.4 13.9 1.36 8.70% 9.2%
GSK NYSE
GlaxoSmithKline
-6.42% 2.63% 46.3% 18.6 8.61 0.38 -25.2% 3.11%
SFZN SW
Siegfried Holding
-4.86% -7.48% 108% 24.2 23.6 1.48 -42.4% -29.3%
AZN NASDAQ
AstraZeneca
-4.86% -8.38% 44% 28.5 15.7 0.95 52.7% 22.3%
IPN PA
Ipsen
-2.2% -6.85% 38.7% 24.1 10.2 0.73 -6.40% -6.33%

Performance Comparison: NVS vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVS
Total Return (including Dividends) NVS XLV S&P 500
1 Month 4.24% 2.14% 5.25%
3 Months 15.16% 0.64% 24.13%
12 Months 16.79% -4.57% 14.15%
5 Years 78.38% 42.89% 111.83%

Trend Score (consistency of price movement) NVS XLV S&P 500
1 Month 56.4% 35.8% 81%
3 Months 85% -28.5% 96.9%
12 Months 24.6% -74.5% 44.9%
5 Years 88.6% 87.9% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month %th65.50 2.05% -0.96%
3 Month %th52.50 14.43% -7.22%
12 Month %th74.50 22.39% 2.31%
5 Years %th90.50 24.84% -15.79%

FAQs

Does Novartis (NVS) outperform the market?

Yes, over the last 12 months NVS made 16.79%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%. Over the last 3 months NVS made 15.16%, while XLV made 0.64%.

Performance Comparison NVS vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

NVS vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -0.1% -1% 23.6% 3%
US NASDAQ 100 QQQ 0.1% -1.1% 22.9% 4%
German DAX 40 DAX 2% 5.7% 11.4% -12%
Shanghai Shenzhen CSI 300 CSI 300 0% 1% 20.2% -3%
Hongkong Hang Seng HSI 0.3% -1.8% 4.1% -22%
India NIFTY 50 INDA 1.7% 0.8% 23.3% 18%
Brasil Bovespa EWZ -2.6% -4.6% -1.5% 7%

NVS vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 1.2% -1.7% 19.5% -8%
Consumer Discretionary XLY 0.4% 1.1% 31.2% -1%
Consumer Staples XLP -0.5% 3.6% 21.9% 8%
Energy XLE -0.5% -2.8% 27.7% 17%
Financial XLF -0.8% -0.8% 18.7% -13%
Health Care XLV 0.4% 2.1% 31% 21%
Industrial XLI -0.2% 0% 15.7% -8%
Materials XLB -2.4% -0% 19.1% 11%
Real Estate XLRE -0.1% 3.3% 23.9% 4%
Technology XLK -0.9% -4.5% 21.3% 6%
Utilities XLU 0.9% 2.5% 20.4% -6%
Aerospace & Defense XAR 2% -2.8% 5% -33%
Biotech XBI -1.1% 0.9% 36.8% 24%
Homebuilder XHB -2.6% -2.8% 30.8% 11%
Retail XRT -2.7% -0.8% 27.9% 5%

NVS vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -1% -4.20% 32.0% 24%
Natural Gas UNG 9.4% 14.1% 40.4% 19%
Gold GLD -0.4% 5.5% 3% -22%
Silver SLV -1.2% -2.7% 6.2% -1%
Copper CPER 0.8% -0.4% 6.5% 6%

NVS vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 1.7% 3.2% 27% 19%
iShares High Yield Corp. Bond HYG 1.1% 2.6% 24.7% 7%